{"nctId":"NCT04551196","briefTitle":"Management of Post-Tonsillectomy Pain in Pediatric Patients","startDateStruct":{"date":"2020-09-28","type":"ACTUAL"},"conditions":["Pain, Postoperative","Tonsillar Hypertrophy","Tonsillitis"],"count":50,"armGroups":[{"label":"Alternating Regimen","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Alternating Acetaminophen and Ibuprofen"]},{"label":"Combined Regimen","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Combined Acetaminophen and Ibuprofen"]}],"interventions":[{"name":"Alternating Acetaminophen and Ibuprofen","otherNames":["Alternating regimen"]},{"name":"Combined Acetaminophen and Ibuprofen","otherNames":["Combined regimen"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* 4 to 17 years of age at time of enrollment\n* Undergoing tonsillectomy with or without adenoidectomy\n* Able to provide informed consent from parent or legal guardian\n* Able to provide assent if subject is a minor of appropriate age\n\nExclusion Criteria:\n\n* Allergy to acetaminophen or ibuprofen\n* Inability for study participant to cooperate with pain assessments\n* Known pregnancy\n* Any condition which would make the participant, in the opinion of the investigator, unsuitable for the study","healthyVolunteers":false,"sex":"ALL","minimumAge":"4 Years","maximumAge":"17 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With FLACC Pain Scores ≥7 From POD 1 Through POD 3","description":"The proportion of FLACC (Faces, Legs, Activity, Cry, and Consolability scale) pain scores ≥7 from POD 1 through POD 3 compared between the combined and the alternating medication regimens.\n\nThe FLACC scale is scored in a range of 0-10 with 0 representing no pain. The scale has five criteria (Faces, Legs, Activity, Cry, and Consolability), which are each assigned a score of 0, 1 or 2.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With FLACC Pain Scores ≥7 on Each Individual POD 1, 3, and 7","description":"The proportion of FLACC (Faces, Legs, Activity, Cry, and Consolability scale) pain scores ≥7 on each individual POD 1, 3, and 7 compared between the combined and the alternating medication regimens.\n\nThe FLACC scale is scored in a range of 0-10 with 0 representing no pain. The scale has five criteria (Faces, Legs, Activity, Cry, and Consolability), which are each assigned a score of 0, 1 or 2.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With FLACC Pain Scores ≥7 From POD 1 Through POD 7","description":"The proportion of cumulative FLACC pain scores ≥7 from POD 1 through POD 7 compared between the combined and the alternating medication regimens.\n\nThe FLACC scale is scored in a range of 0-10 with 0 representing no pain. The scale has five criteria (Faces, Legs, Activity, Cry, and Consolability), which are each assigned a score of 0, 1 or 2.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Faces Pain Scores ≥8 on POD 1, 3, and 7","description":"The proportion of Faces pain scores ≥8 on POD 1, 3, and 7 compared between the combined and the alternating medication regimens.\n\nThe Faces scale shows a series of faces ranging from a happy face at 0, or \"no hurt\", to a crying face at 10, which represents \"hurts like the worst pain imaginable\". Based on the faces and written descriptions, the patient chooses the face that best describes their level of pain.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Cumulative Faces Pain Scores ≥8 From POD 1 Through POD 7","description":"The proportion of cumulative Faces pain scores ≥8 from POD 1 through POD 7 compared between the combined and the alternating medication regimens.\n\nThe Faces scale shows a series of faces ranging from a happy face at 0, or \"no hurt\", to a crying face at 10, which represents \"hurts like the worst pain imaginable\". Based on the faces and written descriptions, the patient chooses the face that best describes their level of pain.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Rescue Medication Usage Through POD 3","description":"The proportion of rescue medication usage from POD 1 through POD 3 compared between the combined and the alternating medication regimens.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Rescue Medication Usage Through POD 7","description":"The proportion of rescue medication usage from POD 1 through POD 7 compared between the combined and the alternating medication regimens.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Proportion of Subjects That Adhere to the Assigned Medication Regimen","description":"Proportion of subjects that adhere to the assigned medication regimen compared between the combined and the alternating medication regimens as determined by the medication log that the participants return at the end of the study.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25","spread":null},{"groupId":"OG001","value":"25","spread":null}]}]}]},{"type":"SECONDARY","title":"Adverse Events","description":"Incidence of adverse events","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":25},"commonTop":["Emesis","Nausea","Pain - Uncontrolled","Bloody Oral Secretions"]}}}